Which drugs are associated with highest risk for being arrested for driving under the influence? A case-control study

Forensic Science International

Volumn 240, Issue , 2014, Pages 21-28

  Bogstrand, Stig Tore ^a,b,c   Gjerde, Hallvard ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c Lovisenberg Deaconal University College   (Norway)

Author keywords

Case control; DUI; Psychoactive substances; Road traffic crash

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALPRAZOLAM; AMPHETAMINE; BENZODIAZEPINE DERIVATIVE; CLONAZEPAM; COCAINE; CODEINE; DIAZEPAM; FLUNITRAZEPAM; METHADONE; METHAMPHETAMINE; MORPHINE; NITRAZEPAM; NORDAZEPAM; OXAZEPAM; TETRAHYDROCANNABINOL; ZOLPIDEM; ZOPICLONE; HYPNOTIC SEDATIVE AGENT; NARCOTIC AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; BLOOD SAMPLING; CAR DRIVING; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG ABUSE; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; MASS SPECTROMETRY; MIDDLE AGED; POLICE; PRIORITY JOURNAL; RISK ASSESSMENT; SEASONAL VARIATION; SEX DIFFERENCE; TRAFFIC ACCIDENT; CHEMISTRY; LEGISLATION AND JURISPRUDENCE; NORWAY; SALIVA; SUBSTANCE-RELATED DISORDERS;

ACCIDENTS, TRAFFIC; ADULT; AUTOMOBILE DRIVING; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; MIDDLE AGED; NARCOTICS; NORWAY; SALIVA; SUBSTANCE-RELATED DISORDERS;

EID: 84899789998     PISSN: 03790738     EISSN: 18726283     Source Type: Journal    
DOI: 10.1016/j.forsciint.2014.03.027     Document Type: Article

References (30)

1. Kuypers K.P., Legrand S.A., Ramaekers J.G., Verstraete A.G. A case-control study estimating accident risk for alcohol, medicines and illegal drugs. PLOS ONE 2012, 7:e43496.
2. Bogstrand S.T., Gjerde H., Normann P.T., Rossow I., Ekeberg O. Alcohol, psychoactive substances and non-fatal road traffic accidents - a case-control study. BMC Public Health 2012, 12:734.
3. Bernhoft I.M., Hels T., Lyckegaard A., Houwing S., Verstraete A.G. Prevalence and risk of injury in Europe by driving with alcohol, illicit drugs and medicines. Procedia Soc. Behav. Sci. 2012, 48:2907-2916.
4. Gjerde H., Christophersen A.S., Normann P.T., Mørland J. Associations between substance use and fatal road traffic accidents among car and van drivers in Norway: a case-control study. Transp. Res. F: Traffic Psychol. Behav. 2013, 17:134-145.
5. Blomberg R.D., Peck R.C., Moskowitz H., Burns M., Fiorentino D. The long beach/Fort Lauderdale relative risk study. J. Safety Res. 2009, 40:285-292.
6. Borkenstein R.F., Crowther R.F., Shumate R.F., Ziel W.B., Zylman R. The role of the drinking driver in traffic accidents (the Grand Rapids study). Blutalkohol 1974, 11:1-131.
7. Vindenes V., Jordbru D., Knapskog A.B., Kvan E., Mathisrud G., Slørdal L., Mørland J. Impairment based legislative limits for driving under the influence of non-alcohol drugs in Norway. Forensic Sci. Int. 2012, 219:1-11.
8. Gjerde H., Bogstrand S.T., Lillsunde P. Why is the odds ratio for involvement in serious road traffic accident among drunk drivers in Norway and Finland higher than in other countries?. Traffic Inj. Prev. 2014, 15:1-15.
9. Houwing S., Hagenzieker M., Mathijssen R.P., Legrand S.A., Verstraete A.G., Hels T., Bernhoft I.M., Simonsen K.W., Lillsunde P., Favretto D., Ferrara S.D., Caplinskiene M., Movig K.L., Brookhuis K.A. Random and systematic errors in case-control studies calculating the injury risk of driving under the influence of psychoactive substances. Accid. Anal. Prev. 2013, 52:144-153.
10. Gjerde H., Christophersen A.S., Normann P.T., Assum T., Øiestad E.L., Mørland J. Norwegian roadside survey of alcohol and drug use by drivers (2008-2009). Traffic Inj. Prev. 2013, 14:443-452.
11. Kristoffersen L., Smith-Kielland A. An automated alcohol dehydrogenase method for ethanol quantification in urine and whole blood. J. Anal. Toxicol. 2005, 29:387-389.
12. Kristoffersen L., Stormyhr L.E., Smith-Kielland A. Headspace gas chromatographic determination of ethanol: the use of factorial design to study effects of blood storage and headspace conditions on ethanol stability and acetaldehyde formation in whole blood and plasma. Forensic Sci. Int. 2006, 161:151-157.
13. Gjerde H., Christophersen A.S., Skuterud B., Klemetsen K., Mørland J. Screening for drugs in forensic blood samples using EMIT urine assays. Forensic Sci. Int. 1990, 44:179-185.
14. Christophersen A.S., Gulliksen M., Hasvold I., Johansen U., Karinen R., Ripel A., Krogh M. Screening, confirmation and quantification of drugs of abuse in whole blood by LC-MS (ESI). Abstracts of the 39th Meeting of the International Association of Forensic Toxicologists (TIAFT), August 26-30, 2001, Prague 2001, Charles University, Prague, Czech Republic, P85 pp. M. Balikova, E. Novakova (Eds.).
15. Øiestad E.L., Johansen U., Øiestad A.M., Christophersen A.S. Drug screening of whole blood by ultra-performance liquid chromatography-tandem mass spectrometry. J. Anal. Toxicol. 2011, 35:280-293.
16. Øiestad E.L., Johansen U., Christophersen A.S. Drug screening of preserved oral fluid by liquid chromatography-tandem mass spectrometry. Clin. Chem. 2007, 53:300-309.
17. Verstraete A., Knoche A., Jantos R., Skopp G., Gjerde H., Vindenes V., Mørland J., Langel K., Lillsunde P. Per Se Limits - Methods of Defining Cut-off Values for Zero Tolerance. DRUID Deliverable D1.4.2 2011, Ghent University, Ghent, Belgium.
18. ® sampling device. J. Anal. Toxicol. 2010, 34:204-209.
19. Strand M.C., Fjeld B., Arnestad M., Mørland J. Psychomotor Relevant Performance: 1. After Single Dose Administration of Opioids, Narcoanalgesics and Hallucinogens to Drug Naïve Subjects; 2. In Patients Treated Chronically with Morphine or Methadone/Buprenorphine. DRUID Deliverable D1. 1.2C 2011, Norwegian Institute of Public Health, Oslo, Norway.
20. Bachs L., Skurtveit S., Mørland J. Codeine and clinical impairment in samples in which morphine is not detected. Eur. J. Clin. Pharmacol. 2003, 58:785-789.
21. Hillestad L., Hansen T., Melsom H. Diazepam metabolism in normal man. II. Serum concentration and clinical effect after oral administration and cumulation. Clin. Pharmacol. Ther. 1974, 16:485-489.
22. KRIPOS Narkotika- og Dopingstatistikk 2012 [Drug and Doping Statistics 2012] 2013, KRIPOS, Oslo, Norway, available from: https://www.politi.no/vedlegg/lokale_vedlegg/kripos/Vedlegg_2013.pdf (accessed 05.11.13).
23. Wille S.M.R., Raes E., Lillsunde P., Gunnar T., Laloup M., Samyn N., et al. Relationship between oral fluid and blood concentrations of drugs of abuse in drivers suspected of DUID. Ther. Drug Monit. 2009, 31:511-519.
24. Langel K., Gjerde H., Favretto D., Lillsunde P., Øiestad E.L., Ferrara S.D., et al. Comparison of drug concentrations between whole blood and oral fluid. Drug Test. Anal. 2013, (in press). 10.1002/dta.1532.
25. Cameron M. Random drug testing in Australia, analogies with RBT, and likely effects with increased intensity levels. Proceedings of the 20th International Council on Alcohol, Drugs and Traffic Safety Conference 2013, 152-159. available from: http://t2013.com/wp-content/uploads/2013/08/160813_ICADTS_Proceedings.pdf (accessed 18.02.14). B. Watson (Ed.).
26. Utrykningspolitiet Førere med høy risikovillighet - En analyse av anmeldte fartsovertredere og rusførere 2012, Temahefte nr 3/2012, Stavern, Norway, available from: https://www.politi.no/vedlegg/lokale_vedlegg/utrykningspolitiet/Vedlegg_1604.pdf (accessed 18.02.14).
27. Christophersen A.S., Skurtveit S., Grung M., Mørland J. Rearrest rates among Norwegian drugged drivers compared with drunken drivers. Drug Alcohol Depend. 2002, 66:85-92.
28. Bogstrand S.T., Middelkoop G., Christophersen A.S. Trends in amphetamine and benzodiazepine use among drivers arrested for drug impaired driving in Norway 2000-2009. Norsk Epidemiol. 2011, 21:61-66. available from: http://www.ntnu.no/ojs/index.php/norepid/article/view/1427/1281 (accessed 18.02.14).
29. Bramness J.G., Skurtveit S., Furu K., Engeland A., Sakshaug S., Rønning M. Endringer i salg og bruk av flunitrazepam etter 1999 [Changes in the sale and use of flunitrazepam in Norway after 1999]. Tidsskr. Nor. Laegeforen. 2006, 126:589-590.
30. International Narcotics Control Board Report of the International Narcotics Control Board 2004 2005, International Narcotics Control Board, Vienna, Austria.